Home » Topics » Regulatory » Patents

Patents
RSS

Wakamoto discovers natural substances for Alzheimer's disease

Oct. 7, 1998

Dopamine reuptake inhibitors synthesized at Pola, useful for Parkinson's disease

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Basic research in the field of vitronectin antagonists revealed by HMR

Oct. 6, 1998

Tanabe presents new antidiabetic agents

Oct. 6, 1998

Antitumor agents with high potency and selectivity under evaluation at Shionogi

Oct. 6, 1998

Banyu patents new series of NPY antagonists for obesity, bulimia, diabetes

Oct. 6, 1998

BASF describes novel inhibitors of cysteine proteases

Oct. 5, 1998

Nonimmunosuppressive rotamase inhibitors under study at Guilford for neurological disorders

Oct. 5, 1998

Cell adhesion inhibitors developed by Sumitomo researchers

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.